Ashwin Kishtagari, Assistant Professor of Medicine, Hematology and Oncology at Vanderbilt University Medical Center, shared on LinkedIn:
“Heading to New Orleans for ASH26 with a full heart.
The moment I’m proudest of this year isn’t mine. Three of the internal medicine residents I mentor have each received an ASH Abstract Achievement Award:
- Akshay Aluri, for “Disease-modification endpoint use in myelofibrosis clinical trials: An analysis of 145 registered trials 2010–2025”
- Michael Zargari, for ‘GLP-1RA exposure and incident persistent cytopenias‘ (Poster, Sat Dec 12, 5:30–7:30 PM, Hall F):
- Pranay Shettywarangale, for ‘Pooled incidence of tumor lysis syndrome in 2,275 patients receiving venetoclax for AML’
Each of them started with a question and the willingness to chase it. Watching residents find their voice in hematology is the best part of this work.
I’ll also be presenting an oral abstract on our all-oral regimen of ASTX727 plus itacitinib in ABNL-MARRO 001, an MDS/MPN International Working Group study, in Session 637 on Sunday, Dec 13, 9:30–11:00 AM in Hall C. Thank you to Michael Savona, our co-investigators across the IWG, and above all the patients and families who made this trial possible.
On Saturday, Dec 12, 4:00–5:30 PM in Hall C, I’m honored to co-moderate the MF and SM oral session with Ruben Mesa, MD, someone whose work shaped how so many of us think about MPNs.
Grateful to Vanderbilt-Ingram Cancer Center and American Society of Hematology. See you in New Orleans!”
The 68th ASH Annual Meeting and Exposition, organized by the American Society of Hematology (ASH), will take place on 12–15 December 2026 at the Ernest N. Morial Convention Center in New Orleans, Louisiana, with both in-person and virtual participation available.
Described by ASH as the world’s largest and most comprehensive hematology meeting, the conference will feature hundreds of sessions presenting the latest research and clinical practice developments across hematology, including the Education Program, Scientific Program, Marquee Sessions, oral and poster presentations, special-interest sessions, exhibits, and industry-related activities.
Other posts about ASH26 on OncoDaily.